Dr Dana Rizk is Professor of Medicine in the Division of Nephrology at the University of Alabama at Birmingham (UAB) and a VOYXACT VISIONARY Study Investigator and Co-Chair of the Steering Committee.

Proteinuria is a condition characterised by the presence of excess protein, mainly albumin, in the urine. Generally, the kidneys filter waste products and excess fluids from the blood and excrete them ...

The novel drug atacicept was associated with significant reductions in proteinuria vs. placebo with comparable safety and no ...

Proteinuria is an unusually high amount of protein in your pee (urine). The condition is often a sign of kidney disease. Your kidneys are filters that don't usually let a lot of protein pass through.

At the American Society of Nephrology Kidney Week meeting, interim results from the phase III ORIGIN 3 trial showed that ...

This year’s most-read articles on CKD highlighted research and insights on drug approvals, guidelines, and value-based care.

Proteinuria, also sometimes referred to as albuminuria or urine albumin is a health condition characterized by an abnormal concentration of protein in the urine. The kidneys continuously filter the ...

Proteinuria is common in the adult population and its clinical significance can vary widely. A clear diagnostic process is needed to identify the cause of the findings and guide the treatment ...

Voyxact, an APRIL inhibitor, receives FDA accelerated approval for adults with primary IgA nephropathy to reduce proteinuria.

Proteinuria refers to elevated protein levels in the urine. It is not a disease but a sign that the kidneys are not correctly filtering blood, possibly due to a kidney condition. Several proteins may ...